Rezultati pretraživanja
  1. prije 6 sati

    IAmBiotech: Coming soon at : Speaker Dr. Benjamin Cowen, of ImmunoMet, a clinical-stage company developing anti-tumor and immune-metabolism therapies. Here's an early look:

  2. Coming soon at : Speaker Dr. Benjamin Cowen, of ImmunoMet, a clinical-stage company developing anti-tumor and immune-metabolism therapies. Here's an early look:

  3. prije 6 sati

    Learn the 10 most common false assumptions made during biopharma partnering deals from expert business development consultant, Linda Pullan, PhD of . Read the blog >> |

  4. prije 6 sati

    Make sure to catch fireside chats from Barbara Dalton of and other key biotech and pharma leaders, including , ; Ted W. Love, ; Michael M. Morrissey, and Carol Lynch, at ! View the complete program⬇️

  5. prije 7 sati
  6. prije 9 sati

    What's next in fighting solid tumors? Dr. Benjamin Cowen, CEO of , a clinical stage biotech company developing anti-tumor and immune-metabolism therapies, will speak about that and his impressive experience in biotech at .

  7. prije 12 sati

    See who you can meet at , the must-attend meeting for top investment firms in the region! More than 340 investors have already registered, including , and .

  8. prije 14 sati

    Thank you for providing scholarships to NYC’s innovative biotechs to attend and pitch investors. See you next week!

  9. prije 17 sati

    We look forward to seeing you in next week! is a proud sponsor of the BIO CEO & Investor Conference Feb. 10-11

  10. 4. velj

    IAmBiotech: Meet ImmunoMet’s Dr. Benjamin Cowen, Speaker at

  11. 4. velj

    Meet ImmunoMet’s Dr. Benjamin Cowen, Speaker at

  12. 4. velj

    💡PANEL SPOTLIGHT💡 Catch the Market Performance and IPO Class of 2020 panel at and examine whether the overall market will experience a cooling off period in 2020 or if we are at the beginning of a long-term growth cycle. View the complete program⬇️

  13. 4. velj

    Our COO/CBO Stephan Lensky is presenting at the BIO CEO & Investor Conference taking place February 10-11 in . Schedule a meeting with us to learn more.

  14. 4. velj
  15. 4. velj

    We’re busy this month! Don’t miss presentations from our CEO, , at ’s and our CTO, Jason Christiansen, at ’ Biomarker and Companion Diagnostics Conference. Details here:

  16. 4. velj

    The Syneos One team at Syneos Health is dedicated to delivering fully integrated solutions focused on cost, speed, and risk mitigation to increase an asset’s NPV. Schedule a meeting with us at to learn more.

  17. 4. velj

    We're presenting at on Monday at 2:15pm EST. Listen to the webcast via the link in our investors section of our website.

  18. 3. velj

    Meet our CEO, Florence Séjourné, at the BIO CEO & Investor Conference taking place in New York on Feb 10-11, to hear about DAV132 Phase 2 results!

  19. 2. velj

    Syneos Health provides capital solutions for biotechs by connecting innovators with the ‘right’ capital sources, and works with both to maximize ROI in a strategic ‘end to end’ model. Schedule a meeting with the Syneos team at to learn more.

  20. 31. sij

    The Syneos One team at Syneos Health optimizes product development, thus creating the potential for cost efficiencies, increased speed to market, and de-risking of investment dollars. Meet us at and learn more.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.